Amyloid beta peptides (Aβ) proteins play a key role in vascular pathology in Alzheimer's Disease (AD) including impairment of the blood brain barrier and aberrant angiogenesis.
Introduction
Alzheimer's disease (AD) is closely associated with alterations in the vascular system.
Multiple studies in humans and animal models have described pathological vascular changes in AD (1) , including disruption to the neurovascular unit (2) and blood-brain barrier (3), increased microvessel density (2, 4, 5) , arteriolar and venular tortuosity (6, 7) , vascular Aβ accumulation (8) and alterations in retinal vasculature (9) . Such changes will likely compromise the effective delivery of oxygen and nutrients to the brain, so understanding whether vascular alterations are a cause or consequence of aspects of AD pathology, notably Aβ accumulation, is required in order to design effective therapies.
Amyloid beta peptides, particularly Aβ1-42, are hallmarks of AD (10) . These peptides are the result of sequential proteolytic cleavage of amyloid precursor protein (APP) by β-and γ-secretase enzyme activity. Whilst it is reported that synapse loss is the best correlate of clinical outcome in AD (11) , it is unclear as to whether pathological APP processing products drive this effect by a direct action on neurons, or indirectly such as through aberrant angiogenesis. Despite widespread interest in the role of brain vasculature in AD, little is known about how amyloid-induced vascular changes alter pathological sprouting angiogenesis.
Endothelial sprouting is a key process of physiological and pathological angiogenesis (12) and is regulated by the NOTCH signaling pathway (13) . NOTCH receptors (NOTCH1-4) undergo proteolytic processing via γ-secretase in a manner comparable to that of APP (14, 15) resulting in the hypothesis that interactions between these signaling pathways could underlie the angiogenic pathology in AD (16, 17) . Pericyte recruitment is closely linked to endothelial cell sprouting. Endothelial tip cells secrete platelet derived growth factor (PDGF) that activates platelet derived growth factor receptor beta (PDGFRβ) on pericytes and induce their migration to the sprout (18, 19) . Organotypic brain slice cultures (OBSCs) provide an excellent platform to explore mechanisms of pathological sprouting angiogenesis in AD. OBSCs initially retain a dense network of capillaries and neurovascular units alongside maintenance of neuronal architecture and non-neuronal cell populations (20) (21) (22) . Crucially, OBSCs provide a 3-dimensional culture system that supports the formation of new blood vessels and are amenable to pharmacological manipulation, live imaging and repeated measurements (23) (24) (25) (26) . We and others have previously shown that OBSCs are powerful tools for investigating the progression of AD-like alterations including Aβ accumulation (27) , synaptic disruption (24) and cerebrovascular damage (28) .
In this study, we used a novel in vitro approach to study sprouting angiogenesis in OBSCs. In tissue from huAPP transgenic mice, we found an increase in sprouting angiogenesis that could be completely blocked by BACE1 inhibition. We investigate the mechanisms by which pathological APP processing and NOTCH signalling interact to induce excessive vascular sprouting and discuss the implications for the blood vessel pathology seen in AD.
Results

Characterisation of sprouting angiogenesis in organotypic brain slice cultures
New blood vessels in the cortex are formed via sprouting angiogenesis, a process driven by specific endothelial tip cells at the leading edge of vascular sprouting. Sprouting angiogenesis encompasses sequential events including; sprouting at the vascular front of endothelial cells, extension of sprouts, the formation of new vascular loops, and pericyte recruitment (12, 29, 30) . We first established an ex vivo cortical organotypic brain slice culture (OBSC) system to analyse this highly regulated process and found we were able to identify multiple stages of sprouting angiogenesis in OBSCs from wild-type (WT) mice (summarised in Fig. 1e ).
PECAM-1 staining (a marker of endothelial cells) showed a dense network of blood vessels expressing basal membrane protein laminin in 7-days in vitro cortical slices (Fig. 1a) .
Endothelial tip cells were found either along the trunk of PECAM-1 + blood vessels with few filopodia (Fig. 1b, asterisk) or at the leading edge of vascular sprouts extending numerous filopodia (Fig. 1b,c) , indicating active sprouting angiogenesis. The filopodia of some vascular sprouts were also found to engage with those of a nearby endothelial tip cells to form a bridge and the formation of new blood vessels (Fig. 1d) .
PDGFRβ + pericytes were found around the OBSC blood vessels and with long cytoplasmic processes surrounding the abluminal surface of endothelium ( Fig. 2a-c) . High magnification confocal imaging showed that PDGFRβ expressing pericytes were closely associated with the PECAM-1 + vascular sprouts ( Fig. 2d-e , framed image) and astrocytes within neurovascular unit ( Fig. 2f-h ) at 7 days in vitro. Taken together, this demonstrates the utility of OBSCs as a tool to assess different steps of sprouting angiogenesis, including filopodia formation and pericyte coverage.
Vascular abnormalities in the cortex and retina of postnatal TgCRND8 mice
In preparation for studying the mechanism in OBSCs, which necessarily require the use of early postnatal tissue, we studied P7 TgCRND8 post mortem mouse cortex and retina to determine whether a mutant huAPP transgene leads to any pathological changes in the organisation of the vascular network and endothelial cell physiology during postnatal development (31, 32) . We first analysed vessel architecture and pericyte coverage in the cortex of P7 mice (Fig. 3) . PECAM-1 expressing cortical blood vessels of P7 TgCRND8 (Fig. 3b, b' ) mice appeared to be more tortuous than cortical vessels of P7 WT mice ( Fig.   3a,a' ). When assessing PDGFRβ + pericyte coverage of blood vessels in P7 TgCRND8 cortex, we found an approximately 2-fold higher pericyte coverage when compared to WT ( Fig. 3c) with coverage becoming almost complete (Fig. 3b) . We next analysed the vascular organisation of the retinal plexus in P7 WT and TgCRND8 animals (Fig. 3d) . PECAM-1 + blood vessels in the retinal plexus of TgCRND8 were larger in diameter and formed a highly dense and more interconnected network compared to WT littermates, indicating aberrant angiogenesis. Thus, several CNS tissues from mutant huAPP transgenic mice show enhanced angiogenesis as early as P7.
Excessive vascular sprouting is associated with increased vascular density and number of pericytes in TgCRND8 OBSCs
We next looked for changes in endothelial filopodia formation, vascular density and pericyte number in 7 days in vitro TgCRND8 OBSCs (Fig. 4) . The capillary density (as measured by area of PECAM-1 staining) was significantly higher in TgCRND8 OBSCs compared to cultures from WT littermates ( Fig. 4a-b) . Confocal microscopy revealed an increase in the number of filopodia found both at the leading edge, as well as along the body, of the vascular sprouts in TgCRND8 cultures (Fig. 4c) alongside a 50% increase in the number of filopodia at the vascular sprout of the blood vessels (Fig. 4d) .
In 7 days in vitro TgCRND8
OBSCs, the number of PDGFRβ + pericytes around the capillaries was significantly higher than WT controls ( Fig. 5a-b) . The increased number of PDGFRβ+ pericytes was correlated with an upregulation of PDGFRβ protein expression as measured by western blot (Fig. 5c-d) .
Inhibition of BACE1 activity normalises vascular density and hypersprouting in
TgCRND8 OBSCs
To investigate if higher vascular density and filopodia number depend on the increased production of Aβ seen in TgCRND8 OBSCs, we applied the BACE1 inhibitor LY2886721 to OBSCs for 7 days in vitro (Fig. 6a) . Using ELISA, we found that BACE1 inhibitor completely abolished the generation of Aβ1-40 and Aβ1-42 in the TgCRND8 OBSC culture medium (Fig. 6b) . Staining for PECAM-1, we found that BACE1 inhibition reduced the vascular density in TgCRND8 slices back to WT levels, with no additional effect on WT cultures (Fig. 6c-e) . Quantification of PECAM-1 + capillaries revealed a two-fold increase in total vessel length in TgCRND8 OBSCs, which was restored to WT levels after BACE1 inhibition (Fig. 6f) . Similarly, BACE1 inhibition reduced the excessive sprouting activity of PECAM-1 + endothelial cells in TgCRND8 OBSCs, significantly lowering the number of filopodia at the leading edge of the vascular sprout back to WT levels ( Fig. 6g-i ). showed that mRNA levels of Notch3 and Jag1 were significantly lower in TgCRND8 retina when compared to the WT controls, whilst expression of Notch1, Jag2 and DLL4 were not significantly changed (Fig. 7a) . Next, we asked whether BACE1 inhibition could rescue mRNA levels of Notch3 and Jag1 in TgCRND8 OBSCs. 5μM BACEI inhibitor treatment for 7 days in vitro normalised both Notch3 and Jag1 mRNA expression back to the levels observed in WT cultures (Fig. 7b,c) . We found no significant changes in the mRNA expression of Notch1, Jag2, DLL4 in TgCRND8 or WT slices after BACE1 inhibitor treatment ( Fig. 7d-e ).
BACE1 inhibition restores
BACE1 inhibition induces cleavage of NOTCH3 intracellular domain (NICD3) in
TgCRND8 cortical slices
Finally, we analysed how higher production of Aβ affects NOTCH3 and NOTCH1 signalling activity in TgCRND8 OBSCs (Fig. 8) . Translocation of the NOTCH intracellular domain (NICD) into the nucleus is a regulator of endothelial sprouting (13), so we tested whether the reduction in Notch3 mRNA led to lower levels of NICD3. Western blot analysis showed a trend for reduced levels of NOTCH3 intracellular domain (NICD3) in TgCRND8 cortical slices. In contrast, BACE1 inhibitor treatment significantly increased NICD3 levels in
TgCRND8 slices to at least the level of WT cortical cultures (Fig. 8a-b) . Consistent with the mRNA levels of Notch1, there was no effect of genotype or BACE1 inhibition on the appearance of NOTCH1 intracellular domain (NICD1) ( Fig. 8c-d ).
Discussion
In this study, we have shown that aspects of vascular pathology seen in AD can be recapitulated in an in vitro system that not only retains microvasculature but supports the growth of new vessels and is amenable to pharmacological manipulation. We show increased angiogenesis in postnatal TgCRND8 cortex, retina and in OBSCs. Using OBSCs, we demonstrated reversal of angiogenic pathology via BACE1 inhibition, alongside restoration of NOTCH signalling.
OBSCs represent a potent tool for exploring vascular phenotypes in a system that retains native cell populations and cytoarchitecture, Until now, whilst the OBSC model has been well established for studying angiogenic processes, (33) , (34), (20) , there were few studies seeking to explore this in combination with AD models. Slices from adult APP_SweDI mice have been found to express L-type calcium channels and substance P around amyloid plaques, pointing to altered angiogenesis at this key pathological site (35) . Another study demonstrated that platelets from an AD mouse model damage healthy cortical vessels and induced Aβ accumulation when infused into wildtype OBSC vessels (28). Here we report, for the first time, pathological sprouting angiogenesis in OBSCs from an AD mouse model that is dependent on BACE1 processing of APP. The increased sprouting angiogenesis, including excessive filopodia formation, and increased pericyte coverage, we observe in TgCRND8
OBSCs is much more pronounced than that seen in vivo at a similar age, but is consistent with the enhanced vascularisation we observed in both retina and cortex. The OBSC culture method likely stresses the tissue via the slicing injury and/or the isolation from the systemic vasculature resulting in stimulation of sprouting angiogenesis. By allowing visualisation of such processes in both WT and TgCRND8 tissue, the OBSC system appears to unmask a mechanism that underlies the vascular changes in AD models that may otherwise be overlooked.
Use of a model that endogenously expresses mutant APP with all its processing products allows for careful exploration of the effects of Aβ as well as other APP-derived products (36) (37) (38) . A potential role for Aβ as a regulator of angiogenesis has been previously proposed based on observations in both physiological and pathological conditions. In post mortem human AD brains, it has been shown that increased vascular density in the hippocampus correlates with Aβ load (5) . In mouse models of amyloid pathology, immunisation with Aβ peptides resulted in plaque clearance in the brain and restored capillary density to normal levels (39) and inhibition of Aβ oligomerisation/ fibrillization reduced arteriolar Aβ accumulation and tortuosity (6) . Application of synthetic Aβ to a number of models has also highlighted its pro-angiogenic role with increased endothelial cell proliferation, capillary bed density and vascular sprouting seen both in vitro and in vivo (16, 40, 41) . Our findings in this study add increasing weight to existing evidence that Aβ or its precursors can stimulate angiogenic processes and we provide a novel OBSC platform to explore the role of endogenously produced Aβ on vascular pathology.
The significance of Aβ here may be as a marker of APP processing or as a cause of pathological angiogenesis. Interestingly, over-production of Aβ in this model is accompanied by reduced expression of the angiogenesis suppressor NOTCH3 and its ligand JAG1, providing a novel mechanistic insight into how amyloid pathology potentially impacts the regulation of angiogenesis in AD. Genetic knockout of Notch3 has previously been shown to increase retinal vascular density and endothelial tip formation in postnatal mice (42) and silencing NOTCH3 in tumours promotes pathological angiogenesis (43) . NOTCH ligand JAG1 has also been implicated in angiogenic processes, with application of Jag1 targeting antisense oligonucleotides potentiating FGF-responsive tube formation and invasion in vitro (44) . There are multiple potential mechanisms by which Notch3 and Jag1 could be downregulated in postnatal TgCRND8 tissue, which we summarise in our working hypothesis (Fig. 9) .
NOTCH proteins and NOTCH ligands are substrates for the γ-secretase presenilin (45), resulting in the production of NICD which translocates to the nucleus to regulate gene expression (Fig. 9a) . Cleavage of NOTCH3 by γ-secretase has been found to induce Notch3
and Jag1 transcription via autoregulatory mechanisms (46) . Previous work has also shown that NOTCH3 activation (by cleavage to NICD3) is prevented by γ-secretase inhibition (47) with γ-secretase treatment found to induce angiogenic sprouting in vitro and in vivo (48) .
Interestingly, this effect is mimicked by the application of synthetic monomeric Aβ potentially pointing to an enzymatic feedback inhibition, whereby high levels of Aβ itself also lower the activity of γ-secretase (40) . In TgCRND8 tissue (Fig. 9b) One of our important findings is that excessive endothelial filopodia formation and reduced NOTCH3 signalling in TgCRND8 OBSCs can be normalized via application of BACE1 inhibitor (Fig. 9b) indicating a likely role for BACE1-dependent APP processing products. inhibition is due to reduced levels of BACE-1 dependent APP processing products, we have to consider the possibility that BACE inhibition has a direct effect on angiogenic processes unrelated to APP. Other studies have found that BACE1 directly regulates JAG1 shedding, with BACE1-/-mice showing an increase in Jag1 levels and downstream NOTCH signalling (54) . This, however, seems an unlikely mechanism in our system due to the observation that BACE1 inhibition has no effect on the levels of Jag1 (Fig. 7c ) or vascular density (Fig. 6 ) in WT OBSCs.
Further mechanistic studies are needed to better understand the interplay between NOTCH signalling and APP processing mechanisms in AD. Here, we propose that APP overexpression or feedback inhibition from high Aβ/ β-CTF concentration in TgCRND8
OBSCs reduces γ-secretase-dependent cleavage of NOTCH3 (Fig. 9) . Our results also indicate that there may be a safe level of BACE1 inhibition that can restore physiological levels of angiogenesis, without inducing angiogenic deficits in healthy tissue. 
Methods
Mice
Organotypic brain slice cultures
Cortical organotypic brain slice cultures were made from humanely sacrificed P6-P9
littermates of either sex according to the method of de Simoni et al and our previous work (24, 56) . Briefly, after schedule 1, brains were kept on ice in dissection buffer (EBSS supplemented with 25mM HEPES and 1 x Penicillin/Streptomycin). 350μm thick sagittal sections of cortex were cut using a Leica VT1000S vibratome and slices collected using a modified sterile 3ml Pasteur pipette. On average 6 cortical slices were collected per pup and stored in dissection buffer on ice until plating. For long term culture, slices were transferred, Probes; Cy3 or Cy5, Jackson,) or biotin-conjugated secondary antibodies (Jackson). DAPI (1μg/mL, Sigma) was used to counterstain nuclei.
Microscopy and Image Analysis
Images were captured via an epifluorescence microscopy system (Leica DM6000B) or using confocal microscopes (Leica, Zeiss LSM780). Figures were composed using Photoshop CS5
software.
Quantification of pericyte number and coverage
To quantify the number of PDGFRβ-positive pericytes, cells were counted using NIH Image 
Capillary density, length and filopodia quantification
For PECAM-1-postive capillary area, sections were analysed with Leica confocal microscope. Three pictures were taken at 20X for each section. ROI size of 733x733 m for confocal images were utilized. The area covered by PECAM-1-positive capillaries was analysed using the NIH ImageJ area measurement tool where pictures were subjected to threshold processing to produce a binary image. The area of PECAM-1 coverage was expressed as percentage of the total area, 3 slices per WT and TgCRND8 pups (n= 4-5 for each genotype) were analysed. The filopodia of vascular sprouts were analysed using zstacked PECAM-1 positive blood vessels.
Protein extraction and Western Blot
OBSCs were scraped off the membrane insert using a scalpel and transferred to 2 x Laemelli buffer supplemented with 10% 2-mercaptethanol (50µL per 3 slices). Samples were boiled exposing the membrane to a charge-coupled device camera (LAS1000, Fujifilm, Tokyo, Japan) using a chemiluminescence kit (Merck Millipore, Billerica, MA, USA). Membranes were stripped and reprobed for β-actin (diluted 1:50 000, Sigma-Aldrich). After densitometric analysis using Image J software, protein levels were calculated as percentage of β-actin expression.
Aβ ELISA
Culture medium from 7 div OBSCs was assayed for human Aβ1-40 and Aβ1-42 using commercially available ELISA kits (Life Technologies: KHB3441 and KHB3481). Briefly, medium was incubated with Aβ detection antibody for 3 hours, washed, and then incubated with an HRP-conjugated antibody for 30 minutes. After another wash step, stabilised chromogen was added for 30 minutes before the adding an acid-based stop solution.
Absorbance was read at 450nm using a PheraStar ELISA plate reader with the standard curve calculated using a 4-parameter fit. Concentration of Aβ in the medium is expressed as pg/ml.
Levels of Aβ were compared between BACE1 treated and DMSO treated TgCRND8 cultures.
Quantification of gene expression by qPCR
Slice cultures were scraped off the membrane and RNA extracted using an RNeasy mini kit (Qiagen). Briefly, 3 slices were homogenised in 350µL lysis buffer RLT supplemented with 1% 2-mercaptethanol. 350μL 70% ethanol (in nuclease free water) was then added and samples transferred to RNeasy RNA collection columns. After several wash steps described in the kit protocol, the RNA was eluted in 20µL nuclease free water, measured and quality tested using a Nanodrop® and frozen at -80ᵒC until use. cDNA synthesis was performed using Script™cDNA Synthesis Kit (Bio-Rad). cDNA was analysed using real-time PCR SsoAdvanced™ SYBR® Green Supermix from Bio-Rad and run on a Bio-Rad CFX96 realtime quantitative PCR (qPCR) system. Gene expression was normalized to the housekeeping gene GAPDH. Melt curve analyses were performed to ensure the specificity of qPCR product. Primer sequences will be provided on request. Values are presented as mean ± SD of three independent experiments, and within each experiment, triplicate samples were assessed.
Statistical Analysis
Statistical analysis was conducted using Graph Pad Prism . Data are expressed as mean ± SD.
Two group comparison was performed by using Student's t-test and multiple group comparison by one-way or two-way ANOVA followed by Tukey post hoc test. For Western blot, after normalisation to the actin signal, the ipsilateral expression of each junction protein was compared with the using a two-way ANOVA, followed by Tukey post hoc test.
Significance was set at p<0.05. inhibitor treatment normalised the expression levels of Notch3 (b) and Jag1 (c) in TgCRND8 cortical slices (mean ± SD, n=5 (WT), n=6 (TgCRDN8), *P0.05 and **P0.01, two-way ANOVA). BACE1 inhibitor treatment had no effect on the expression of Notch1 (d), Jag2
(e), and DLL4 (f) in 7 days in vitro TgCRND8 or WT cortical slices, (mean ± SD, n=5 (WT), n=6 (TgCRND8), P>0.05, two-way ANOVA). 
